Medicare Enrolled
Dr. Keith Fiman, M.D.
Gastroenterology · Piedmont, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fiman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fiman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fiman
Dr. Keith Fiman is a gastroenterology specialist in Piedmont, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Fiman performed 1,559 Medicare services across 943 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fiman received a total of $13,392 from 49 pharmaceutical and/or device companies across 639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fiman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in CA
$13,392 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,559
Medicare services
Top 16% in CA for gastroenterology
943
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~78 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
377 | $35 | $152 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
295 | $59 | $148 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
212 | $46 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
143 | $88 | $217 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
85 | $206 | $1,067 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
84 | $96 | $847 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
80 | $70 | $680 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
62 | $70 | $219 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
44 | $50 | $152 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
40 | $178 | $778 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $119 | $332 |
| External hemorrhoid removal by rubber banding A procedure to remove external hemorrhoids using rubber bands to cut off blood supply. The affected tissue is tied off and eventually falls off. |
22 | $200 | $784 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $35 | $100 |
| Anoscopy A diagnostic exam of the anus using a thin, lighted tube called an endoscope to look inside. |
18 | $86 | $181 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
16 | $113 | $701 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
14 | $146 | $781 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
12 | $182 | $781 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,392
Total received (2018-2024)
Avg $1,913/year across 7 years
Top 15% in CA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
639
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,379 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,854
2023
$3,421
2022
$2,097
2021
$2,047
2020
$625
2019
$1,365
2018
$1,983
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$357
Janssen Biotech, Inc.
$311
ABBVIE INC.
$275
Johnson & Johnson Health Care Systems Inc.
$229
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$148
Janssen Scientific Affairs, LLC
$130
Phathom Pharmaceuticals, Inc.
$60
Celgene Corporation
$59
Boston Scientific Corporation
$54
Merck Sharp & Dohme LLC
$52
PFIZER INC.
$51
GENZYME CORPORATION
$37
Gilead Sciences, Inc.
$32
Lilly USA, LLC
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
SHIELD THERAPEUTICS INC
$16
Top 3 companies account for 50.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$2,095
Takeda Pharmaceuticals U.S.A., Inc.
$1,809
ABBVIE INC.
$1,524
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$925
PFIZER INC.
$817
Celgene Corporation
$762
Janssen Scientific Affairs, LLC
$590
AbbVie Inc.
$463
AbbVie, Inc.
$456
Johnson & Johnson Health Care Systems Inc.
$354
RedHill Biopharma Inc.
$316
Merck Sharp & Dohme Corporation
$288
Amgen Inc.
$280
Synergy Pharmaceuticals Inc
$219
Merck Sharp & Dohme LLC
$215
Nestle HealthCare Nutrition Inc.
$207
Ferring Pharmaceuticals Inc.
$183
Lilly USA, LLC
$167
Allergan Inc.
$162
Ardelyx, Inc.
$145
Gilead Sciences, Inc.
$133
Prometheus Laboratories Inc.
$98
Covidien LP
$93
Organon LLC
$89
GENZYME CORPORATION
$84
Braintree Laboratories, Inc.
$77
Boston Scientific Corporation
$76
ERBE USA Inc
$63
Phathom Pharmaceuticals, Inc.
$60
Regeneron Healthcare Solutions, Inc.
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
NESTLE HEALTHCARE NUTRITION INC.
$45
QOL Medical, LLC
$45
Evoke Pharma, Inc.
$44
Teva Pharmaceuticals USA, Inc.
$43
Blueprint Medicines Corporation
$40
Olympus America Inc.
$35
Intercept Pharmaceuticals, Inc.
$34
UCB, Inc.
$34
Endo Pharmaceuticals Inc.
$31
Cumberland Pharmaceuticals, Inc.
$30
Ironwood Pharmaceuticals, Inc
$27
Curium US LLC
$23
BOSTON SCIENTIFIC CORPORATION
$23
Shield Therapeutics Inc
$21
Alfasigma USA, Inc.
$17
IRONWOOD PHARMACEUTICALS, INC
$16
SHIELD THERAPEUTICS INC
$16
AMAG Pharmaceuticals, Inc.
$12
Top 3 companies account for 40.5% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AMJEVITA · APRISO · AVSOLA · Aemcolo · CAPTIVATOR II · CIMZIA · CLENPIQ · CYCLOSET · CYLTEZO · Cimzia · Creon · DARZALEX · DEXILANT · DIFICID · DUPIXENT · Detectnet · Dexilant · ENTYVIO · EOHILIA · ERBE; VIO200S · Entyvio · Erbe VIO3 · FERAHEME · GATTEX · GENERAL ENDOCHOICE · GIMOTI · HADLIMA · HUMIRA · Humira · IBSRELA · INFLECTRA · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · Mavyret · Motegrity · Movantik · NASCOBAL · OCALIVA · OMVOH · Olympus EndoTherapy Accessories · Olympus GI Accessories · Olympus Hemostasis Devices · Omeclamox · REBYOTA · RELISTOR ORAL · REMICADE · RENFLEXIS · RINVOQ · Rotatable Snare · SKYRIZI · STELARA · SUPREP · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · VELSIPITY · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · XIFIXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
209
Per 100K population
12.7
County median income
$126,240
Nearest hospital
KAISER FOUNDATION HOSPITAL - OAKLAND/RICHMOND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fiman is a clinical cardiology specialist, with above-average Medicare volume (top 16% in CA), with low-engagement industry engagement in the top 15% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fiman experienced with chronic care management, additional 20 min/month?
Based on Medicare claims data, Dr. Fiman performed 377 chronic care management, additional 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fiman receive payments from pharmaceutical companies?
Yes. Dr. Fiman received a total of $13,392 from 49 companies across 639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fiman's costs compare to other gastroenterologists in Piedmont?
Dr. Fiman's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fiman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Piedmont
Browse gastroenterologists in Piedmont ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in CA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in CA
Which CA gastroenterologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology